Strongly Magnetic Iron Nanoparticles Improve the Diagnosis of Small Tumours in the Reticuloendothelial System by Magnetic Resonance Imaging

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Ferguson, Peter M ^a,b   Feindel, Kirk W ^c   Slocombe, Angela ^d   MacKay, Matthew ^d   Wignall, Trudy ^d   Delahunt, Brett ^b   Tilley, Richard D ^a   Hermans, Ian F ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d WELLINGTON HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; IMAGE ANALYSIS; IMAGE DISPLAY; IN VIVO STUDY; LYMPH NODE METASTASIS; MICROMETASTASIS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; RETICULOENDOTHELIAL NEOPLASM; SENSITIVITY AND SPECIFICITY; SPLEEN; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; METAL NANOPARTICLES; MICE; MONONUCLEAR PHAGOCYTE SYSTEM;

EID: 84874264991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056572     Document Type: Article

References (24)

1. Kroon BK, Horenblas S, Lont AP, Tanis PJ, Gallee MPW, et al. (2005) Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol 173: 816-819.
2. Johnson PM, Porter GA, Ricciardi R, Baxter NN, (2006) Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 24: 3570-3575.
3. Nakagawa T, Martinez SR, Goto Y, Koyanagi K, Kitago M, et al. (2007) Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes. Clin Cancer Res 13: 4105-4110.
4. Bellin MF, Lebleu L, Meric JB, (2003) Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom. Imaging 28: 155-163.
5. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348: 2491-2499.
6. Saksena MA, Saokar A, Harisinghani MG, (2006) Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging. Eur J Radiol 58: 367-374.
7. Motomura K, Ishitobi M, Komoike Y, Koyama H, Inaji H, et al. (2011) SPIO-enhanced magnetic resonance imaging for the detection of metastases in sentinel nodes localized by computed tomography lymphography in patients with breast cancer. Ann Surg Oncol 18: 3422-9.
8. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, et al. (1990) Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175: 494-498.
9. European Medicines Authority (2008) Withdrawal Assessment Report for Sinerem. EMA: EMEA/CHMP/11527/2008. Available: http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500067463.pdf. Accessed 29 September 2012.
10. Wu L, Cao Y, Liao C, Huang J, Gao F, (2011) Diagnostic performance of USPIO-enhanced MRI for lymph-node metastases in different body regions: A meta-analysis. Eur J Radiol 80: 582-589.
11. Motomura K, Ishitobi M, Komoike Y, Koyama H, Noguchi A, et al. (2011) SPIO-enhanced magnetic resonance imaging for the detection of metastases in sentinel nodes localized by computed tomography lymphography in patients with breast cancer. Ann Surg Oncol 18: 3422-9.
12. Cheong S, Ferguson P, Feindel KW, Hermans IF, Callaghan PT, et al. (2011) Simple synthesis and functionalization of iron nanoparticles for magnetic resonance imaging. Angew Chem Int Ed 50: 4206-4209.
13. Herman DAJ, Ferguson P, Cheong S, Hermans IF, Ruck BJ, et al. (2011) Hot-Injection Synthesis of Iron/Iron Oxide Core/Shell Nanoparticles for T2 Contrast Enhancement in Magnetic Resonance Imaging. Chem Comm 47: 9221-9223.
14. Cheong S, Ferguson P, Hermans IF, Jameson GNL, Prabakar S, et al. (2012) Synthesis and Stability of Highly Crystalline and Stable Iron/Iron Oxide Core/Shell Nanoparticles for Biomedical Applications. ChemPlusChem 77: 135-140.
15. Fauconnier N, Pons JN, Roger J, Bee A, (1997) Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid. J Colloid Interface Sci 194: 427-433.
16. Pisanic TR, Thomas R, Blackwell JD, Shubayev VI, Finones RR, et al. (2007) Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomater 28: 2572-2581.
17. Tiefenauer LX, Tschirky A, Kühne G, Andres RY, (1996) In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI. Magn. Reson. Imaging 14: 391-402.
18. van den Brekel MW, Castelijns JA, Snow GB, (1998) The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it? Am. J. Neuroradiol 19: 695-700.
19. Heesakkers RAM, Hövels AM, Jager GJ, van den Bosch HCM, Witjes JA, et al. (2008) MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 9: 850-856.
20. Harisinghani MG, (2006) Ferumoxtran-10-Enhanced MR Lymphangiography: Does Contrast-Enhanced Imaging Alone Suffice for Accurate Lymph Node Characterization? Am J Roentgenol 186: 144-148.
21. Willinek WA, Schild HH, (2008) Clinical advantages of 3.0T MRI over 1.5T. Eur J Radiol 65: 2-14.
22. Tudorica LA, Oh KY, Roy N, Kettler MD, Chen Y, et al. (2012) A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settings. Magn Reson Imaging 30: 1257-1267.
23. Klumpp BD, Aschoff P, Schwenzer N, Fenchel M, Koenigsrainer I, et al. (2012) Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings. Abdom Imaging 37: 834-842.
24. Bittencourt LK, Barentsz JO, de Miranda LCD, Gasparetto EL, (2012) Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours. Eur Radiol 22: 468-475.